Using, additional RNAseq data from melanoma cells lines (M229 and M397; GSE110054 (Tsoi et al, 2018)), we confirmed that the acquisition of BRAFi resistance correlates with a late increase in the expression of AhR‐associated gene‐signature (Appendix Fig S3B). This evidence concerns the gene AHR and melanoma.